Banner Life Sciences mourns the loss of its president, Michael Lytton...


In-licensing. Out-licensing. Strategic Life-Cycle Management. 

Business Development

At Banner Life Sciences™, our business development strategy is to build our presence as a specialty pharmaceutical company with a clear focus on pharmaceutical products, which leverage proprietary technologies and offer real clinical advantages.

The goal of every partnership is to create innovative, demand-driven products that not only provide people with better health solutions but also offer commercial advantages and valuable IP protection for our business partners.

Banner Life Sciences creates value through a number of strategic activities:

  • In-licensing and acquiring drug formulation technologies that enhance our existing programs in pain, gastroenterology, oncology, and nephrology

  • In-licensing and acquiring reformulated drug assets where we can create synergies within our current therapeutic areas

  • In-licensing and acquiring assets in new specialty areas where we can create value by leveraging our existing drug development, clinical, and regulatory expertise

  • Acquisition of companies that fit within our specialty model, leverage our existing assets and expertise, plus provide us with greater scale.

  • Out-licensing deprioritized drug development programs

Interested in Partnering?